Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hypersensitivity Reaction

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 52 articles:
HTML format



Single Articles


    May 2021
  1. REICH K, Teixeira HD, de Bruin-Weller M, Bieber T, et al
    Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet. 2021 May 20. pii: S0140-6736(21)00589.
    PubMed     Abstract available


  2. GUTTMAN-YASSKY E, Teixeira HD, Simpson EL, Papp KA, et al
    Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials.
    Lancet. 2021 May 20. pii: S0140-6736(21)00588.
    PubMed     Abstract available


  3. THYSSEN JP, Thomsen SF
    Treatment of atopic dermatitis with biologics and Janus kinase inhibitors.
    Lancet. 2021 May 20. pii: S0140-6736(21)00717.
    PubMed    


    January 2021
  4. SIMPSON EL, Bieber T, Thyssen JP, Valdez H, et al
    Abrocitinib for atopic dermatitis - Authors' reply.
    Lancet. 2021;397:196.
    PubMed    


  5. UPPAL SK, Chat VS, Kearns DG, Wu JJ, et al
    Abrocitinib for atopic dermatitis.
    Lancet. 2021;397:195-196.
    PubMed    


    September 2020
  6. SUNYER J, Anto JM
    Asthma exacerbations, air pollution, and allergens.
    Lancet. 2020;396:753.
    PubMed    


  7. BURNEY P, Amaral AFS
    Asthma exacerbations, air pollution, and allergens - Authors' reply.
    Lancet. 2020;396:753-754.
    PubMed    


  8. VON MUTIUS E, Smits HH
    Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention.
    Lancet. 2020 Sep 7. pii: S0140-6736(20)31861.
    PubMed     Abstract available


    August 2020
  9. LANGAN SM, Irvine AD, Weidinger S
    Atopic dermatitis.
    Lancet. 2020;396:345-360.
    PubMed     Abstract available


    July 2020
  10. SIMPSON EL, Sinclair R, Forman S, Wollenberg A, et al
    Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Lancet. 2020;396:255-266.
    PubMed     Abstract available


  11. WEIDINGER S, Schreiber S
    Abrocitinib for atopic dermatitis: a step forward.
    Lancet. 2020;396:215-217.
    PubMed    


  12. LAM RPK, Wong KW, Wan CK
    Allergic contact dermatitis and tracheobronchitis associated with repeated exposure to tear gas.
    Lancet. 2020 Jul 13. pii: S0140-6736(20)31560.
    PubMed    


    February 2020
  13. PERRETT KP, Peters RL
    Emollients for prevention of atopic dermatitis in infancy.
    Lancet. 2020 Feb 19. pii: S0140-6736(19)33174.
    PubMed    


  14. SKJERVEN HO, Rehbinder EM, Vettukattil R, LeBlanc M, et al
    Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial.
    Lancet. 2020 Feb 19. pii: S0140-6736(19)32983.
    PubMed     Abstract available


  15. CHALMERS JR, Haines RH, Bradshaw LE, Montgomery AA, et al
    Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial.
    Lancet. 2020 Feb 19. pii: S0140-6736(19)32984.
    PubMed     Abstract available


  16. PERKIN MR
    Perception of severity of adverse events in oral immunotherapy.
    Lancet. 2020;395:415.
    PubMed    


  17. PETERS MC, Wenzel SE
    Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma.
    Lancet. 2020;395:371-383.
    PubMed     Abstract available


    December 2019
  18. BURNEY P, Amaral AFS
    Air pollution and chronic airway disease: is the evidence always clear?
    Lancet. 2019;394:2198-2200.
    PubMed    


    November 2019
  19. BACHERT C, Han JK, Desrosiers M, Hellings PW, et al
    Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Lancet. 2019;394:1638-1650.
    PubMed     Abstract available


    October 2019
  20. THANGARAJU P, Venkatesan S
    A double blow for a patient with leprosy: a reversal reaction and an adverse drug reaction.
    Lancet. 2019;394:1450.
    PubMed    


  21. VAN REE R
    Sustained unresponsiveness in peanut oral immunotherapy.
    Lancet. 2019;394:1392-1393.
    PubMed    


    September 2019
  22. FITZGERALD JM, Sadatsafavi M
    Triple therapy in a single inhaler: a new option for uncontrolled asthma.
    Lancet. 2019 Sep 30. pii: S0140-6736(19)32216.
    PubMed    


  23. VIRCHOW JC, Kuna P, Paggiaro P, Papi A, et al
    Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials.
    Lancet. 2019 Sep 30. pii: S0140-6736(19)32215.
    PubMed     Abstract available


  24. CHINTHRAJAH RS, Purington N, Andorf S, Long A, et al
    Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.
    Lancet. 2019 Sep 12. pii: S0140-6736(19)31793.
    PubMed     Abstract available


    August 2019
  25. GAUTHIER M, Wenzel SE
    As-needed beta agonist-inhaled corticosteroid in mild asthma.
    Lancet. 2019 Aug 23. pii: S0140-6736(19)31994.
    PubMed    


  26. HARDY J, Baggott C, Fingleton J, Reddel HK, et al
    Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
    Lancet. 2019 Aug 23. pii: S0140-6736(19)31948.
    PubMed     Abstract available


    June 2019
  27. BRUSSELLE GG, Ko FW
    Prevalence and burden of asthma in China: time to act.
    Lancet. 2019 Jun 20. pii: S0140-6736(19)31349.
    PubMed    


  28. HUANG K, Yang T, Xu J, Yang L, et al
    Prevalence, risk factors, and management of asthma in China: a national cross-sectional study.
    Lancet. 2019 Jun 20. pii: S0140-6736(19)31147.
    PubMed     Abstract available


  29. ROBERTS G, Angier E
    Peanut oral immunotherapy: balancing benefits and risks for individuals.
    Lancet. 2019;393:2180-2181.
    PubMed    


    April 2019
  30. CHU DK, Wood RA, French S, Fiocchi A, et al
    Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety.
    Lancet. 2019 Apr 25. pii: S0140-6736(19)30420.
    PubMed     Abstract available


    March 2019
  31. THE LANCET
    Health and wellbeing in adolescence and early adulthood.
    Lancet. 2019;393:847.
    PubMed    


    December 2018
  32. BLUMENTHAL KG, Peter JG, Trubiano JA, Phillips EJ, et al
    Antibiotic allergy.
    Lancet. 2018 Dec 14. pii: S0140-6736(18)32218.
    PubMed     Abstract available


    September 2018
  33. VALENZUELA PL, Santos-Lozano A, Morales JS, Drobnic F, et al
    Free to breathe hard in the Tour de France.
    Lancet. 2018;392:1114-1115.
    PubMed    


    April 2018
  34. RIEDL MA, Relan A, Harper JR, Cicardi M, et al
    C1 esterase inhibitor concentrates and attenuated androgens - Authors' reply.
    Lancet. 2018;391:1356.
    PubMed    


  35. MULLER YD, Harr T, Dayer E, Seebach JD, et al
    C1 esterase inhibitor concentrates and attenuated androgens.
    Lancet. 2018;391:1355-1356.
    PubMed    


    February 2018
  36. THE LANCET
    Asthma in US children.
    Lancet. 2018;391:632.
    PubMed    


    January 2018
  37. MOSLER G, Euba T
    Taking control through drama.
    Lancet. 2018;391:303-304.
    PubMed    


  38. WATTS G
    Ian Pavord: engaging with the eosinophil.
    Lancet. 2018;391:301.
    PubMed    


  39. CROOKS MG, Faruqi S, Morice AH
    How does azithromycin improve asthma exacerbations?
    Lancet. 2018;391:28.
    PubMed    


  40. GIBSON PG
    How does azithromycin improve asthma exacerbations? - Author's reply.
    Lancet. 2018;391:28-29.
    PubMed    


    December 2017
  41. PAPI A, Brightling C, Pedersen SE, Reddel HK, et al
    Asthma.
    Lancet. 2017 Dec 19. pii: S0140-6736(17)33311.
    PubMed     Abstract available


    October 2017
  42. AERTS O, Herman A, Bruze M, Goossens A, et al
    FreeStyle Libre: contact irritation versus contact allergy.
    Lancet. 2017;390:1644.
    PubMed    


    September 2017
  43. KLEINERT S, Horton R
    After asthma: airways diseases need a new name and a revolution.
    Lancet. 2017 Sep 11. pii: S0140-6736(17)32205.
    PubMed    


  44. PAVORD ID, Beasley R, Agusti A, Anderson GP, et al
    After asthma: redefining airways diseases.
    Lancet. 2017 Sep 11. pii: S0140-6736(17)30879.
    PubMed    


  45. CAMARGO CA JR
    Transformational thinking about asthma.
    Lancet. 2017 Sep 11. pii: S0140-6736(17)32126.
    PubMed    


  46. WOODCOCK A, Vestbo J, Bakerly ND, New J, et al
    Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial.
    Lancet. 2017 Sep 8. pii: S0140-6736(17)32397.
    PubMed     Abstract available


  47. GIBSON P
    Effectiveness trials in asthma: time to SaLSA?
    Lancet. 2017 Sep 8. pii: S0140-6736(17)32398.
    PubMed    


    July 2017
  48. BRUSSELLE G, Pavord I
    Azithromycin in uncontrolled asthma.
    Lancet. 2017 Jul 4. pii: S0140-6736(17)31547.
    PubMed    


    March 2017
  49. FITZGERALD JM, Emery P
    Modifying the trajectory of asthma-are there lessons from the use of biologics in rheumatology?
    Lancet. 2017;389:1082-1084.
    PubMed    


    December 2016
  50. WENZEL SE, Jayawardena S, Graham NM, Pirozzi G, et al
    Severe asthma and asthma-chronic obstructive pulmonary disease syndrome - Authors' reply.
    Lancet. 2016;388:2742.
    PubMed    


  51. XIA Y, Cao C, Li W, Shen H, et al
    Severe asthma and asthma-chronic obstructive pulmonary disease syndrome.
    Lancet. 2016;388:2741-2742.
    PubMed    


    October 2016
  52. ZINK A, Bohner A, Schuch A, Biedermann T, et al
    Systemic mastocytosis with generalised skin involvement.
    Lancet. 2016 Oct 13. pii: S0140-6736(16)31710.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: